Literature DB >> 31708662

Lack of accountability in upholding authorship standards in prominent medical oncology clinical trials.

D Y Gui1, G J Weiss1,2.   

Abstract

Authorship in biomedical publications is critical for establishing accountability and contribution toward clinical and scientific research. We examined the frequency of discordance in authorship between presentations of clinical trial data at annual meetings of the American Society of Clinical Oncology and the subsequent peer-reviewed publications. We found that more than 70% of subsequent publications had additional authors not originally present on the abstract despite there being no changes in trial accrual or trial design. This pervasive discordance in authorship demonstrates a lack of uniformity and accountability in authorship reporting standards. 2019 Multimed Inc.

Keywords:  Clinical trials; authorship; honorary

Year:  2019        PMID: 31708662      PMCID: PMC6821121          DOI: 10.3747/co.26.4789

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  5 in total

1.  Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.

Authors:  Kaye L Johnston; Ronald S Go
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506

2.  Financial Conflicts of Interest Among Hematologist-Oncologists on Twitter.

Authors:  Derrick L Tao; Aaron Boothby; Joel McLouth; Vinay Prasad
Journal:  JAMA Intern Med       Date:  2017-03-01       Impact factor: 21.873

3.  Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment.

Authors:  Francisco E Vera-Badillo; Alberto Ocana; Arnoud J Templeton; Ariadna Tibau; Eitan Amir; Ian F Tannock
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

4.  Honorary and ghost authorship in reports of randomised clinical trials in oncology.

Authors:  Francisco Emilio Vera-Badillo; Marc Napoleone; Monika K Krzyzanowska; Shabbir M H Alibhai; An-Wen Chan; Alberto Ocana; Arnoud J Templeton; Bostjan Seruga; Eitan Amir; Ian F Tannock
Journal:  Eur J Cancer       Date:  2016-08-06       Impact factor: 9.162

5.  Financial conflicts of interest among editorialists in high-impact journals.

Authors:  V Kaestner; V Prasad
Journal:  Blood Cancer J       Date:  2017-09-15       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.